Therapeutic plasma exchange therapy support for critical COVID-19: A case report

Ther Apher Dial. 2021 Aug;25(4):533-535. doi: 10.1111/1744-9987.13586. Epub 2020 Nov 3.

Authors

Tianfeng Hua¹, Ming Li², Xiuyong Li³

Affiliations

¹ The Second Department of Intensive Care Unit, No. 2 Hospital Affiliated to Anhui Medical University, Hefei, China.
² The Department of Hepatology, No. 2 People's Hospital of Fuyang City, Fuyang, Anhui, China.
³ The Department of Nephrology, No. 2 People's Hospital of Fuyang City, Fuyang, Anhui, China.

PMID: 32940386
DOI: 10.1111/1744-9987.13586

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antiviral Agents* / administration & dosage
Antiviral Agents* / blood
COVID-19* / immunology
COVID-19* / physiopathology
COVID-19* / therapy
Clinical Deterioration
Cytokine Release Syndrome* / blood
Cytokine Release Syndrome* / etiology
Cytokine Release Syndrome* / therapy
Humans
Interleukin-6 / blood*
Lung / diagnostic imaging
Male
Medication Therapy Management
Plasma Exchange / methods*
Plasma*
Respiration, Artificial / methods
SARS-CoV-2
Severity of Illness Index
Tomography, X-Ray Computed / methods
Treatment Outcome

Substances

Antiviral Agents
Interleukin-6